CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
HOUSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, November 7th by Aravive, Inc. (Nasdaq: ARAV), please note that in the last sentence of the second paragraph, the year for the IgA Nephropathy study should …